Moderna (NASDAQ:MRNA) Unveils Vaccine Pipeline Beyond COVID-19

Moderna (NASDAQ:MRNA) gave some key updates regarding its pipeline ahead of its Vaccine Day event and made it clear that the biotech company has more to offer beyond its COVID-19 vaccines. Read More

Moderna Says New Covid Shot Hit Goal in Late-Stage Trial

The new version of Moderna Inc.’s Covid-19 vaccine hit its goal in a late-stage trial, the company said, helping pave the way for a shot that’s easier to use and more potent for the elderly ... Read More

Vaccines News

Optimizing Boosters: How COVID mRNA Vaccines Reshape Immune Memory After Each Dose Mar. 8, 2024 — COVID-19 vaccines elicit ... antibodies targeting a hard-to-spot region of the influenza virus ... Read More

Moderna’s New COVID-19 Vaccine Elicits Strong Immune Response in Phase 3 Trial

The safety profile of mRNA-1283 was found to be similar to the currently approved Moderna COVID-19 vaccines. Positive results were observed in a phase 3 trial evaluating Moderna’s next ... Read More

WHO Calls for Vaccine Patent Pool as Virus Spreads in Developing World

(AP Photo/Tsvangirayi Mukwazhi) (CN) — With the coronavirus pandemic spreading faster in the developing world, the World Health Organization and national leaders on Friday launched a plea to ensure ... Read More

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge

A Delaware District Court sided with Arbutus Biopharma Corporation (NASDAQ:ABUS) and Genevant Sciences in their ongoing patent infringement case against Moderna Inc (NASDAQ:MRNA) COVID-19 vaccine. Read More

Moderna's MRNA-1283 COVID-19 Vaccine Design Meets Primary Endpoints In Phase 3 Clinical Trial

(RTTNews) - Moderna, Inc. (MRNA) announced on Tuesday that its next-generation COVID-19 vaccine design mRNA-1283 has met the primary endpoints of the NextCOVE Phase 3 clinical trial. The trial ... Read More

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials

Announces next-generation COVID-19 vaccine candidate as ... MA / ACCESSWIRE / March 27, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced at its fifth Vaccines Day event clinical and program ... Read More

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

mRNA-1283 induced a more robust immune response compared to Spikevax ® COVID-19 vaccine ... Moderna values and mindsets to responsibly change the future of human health, Moderna strives to ... Read More

World News

Israeli officials say they didn’t see a strike on a high-level Iranian target in Syria as a provocation, and did not give Washington a heads-up about it until right before it happened. By ... Read More

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine

CAMBRIDGE, MA / ACCESSWIRE / March 26, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine ... strives to deliver the greatest ... Read More